114 related articles for article (PubMed ID: 32818800)
1. Differential tissue specific expression of Kif23 alternative transcripts in mice with the human mutation causing congenital dyserythropoietic anemia type III.
Vikberg AL; Malla S; Golovleva I
Blood Cells Mol Dis; 2020 Nov; 85():102483. PubMed ID: 32818800
[TBL] [Abstract][Full Text] [Related]
2. Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23.
Liljeholm M; Irvine AF; Vikberg AL; Norberg A; Month S; Sandström H; Wahlin A; Mishima M; Golovleva I
Blood; 2013 Jun; 121(23):4791-9. PubMed ID: 23570799
[TBL] [Abstract][Full Text] [Related]
3. Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene.
Méndez M; Moreno-Carralero MI; Peri VL; Camacho-Galán R; Bosch-Benítez JM; Huerta-Aragonés J; Sánchez-Calero-Guilarte J; Moreno-Risco MB; Alonso-Domínguez JM; Morán-Jiménez MJ
Ann Hematol; 2021 Feb; 100(2):353-364. PubMed ID: 33159567
[TBL] [Abstract][Full Text] [Related]
4. Congenital dyserythropoietic anemias: molecular insights and diagnostic approach.
Iolascon A; Heimpel H; Wahlin A; Tamary H
Blood; 2013 Sep; 122(13):2162-6. PubMed ID: 23940284
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Novel Mutation in the SEC23B Gene Associated With Congenital Dyserythropoietic Anemia Type II Through the Use of Next-generation Sequencing Panel in an Undiagnosed Case of Nonimmune Hereditary Hemolytic Anemia.
Aydin Koker S; Karapinar TH; Oymak Y; Bianchi P; Fermo E; Gozmen S; Vergin C
J Pediatr Hematol Oncol; 2018 Oct; 40(7):e421-e423. PubMed ID: 29846281
[TBL] [Abstract][Full Text] [Related]
6. Kinesin family members KIF11 and KIF23 as potential therapeutic targets in malignant pleural mesothelioma.
Kato T; Lee D; Wu L; Patel P; Young AJ; Wada H; Hu HP; Ujiie H; Kaji M; Kano S; Matsuge S; Domen H; Kaga K; Matsui Y; Kanno H; Hatanaka Y; Hatanaka KC; Matsuno Y; de Perrot M; Yasufuku K
Int J Oncol; 2016 Aug; 49(2):448-56. PubMed ID: 27279560
[TBL] [Abstract][Full Text] [Related]
7. Novel mutation in KIF23 causing congenital dyserythropoietic anemia type III in patients who underwent allogeneic hematopoietic stem cell transplantation.
Fujikawa T; Uemura S; Hasegawa D; Morisada N; Nakamura S; Kozaki A; Saito A; Kishimoto K; Ishida T; Mori T; Yakushijin K; Katayama Y; Yamashita D; Wakamatsu M; Hamada M; Muramatsu H; Takahashi Y; Kosaka Y
Pediatr Blood Cancer; 2024 Jun; 71(6):e30736. PubMed ID: 38523246
[No Abstract] [Full Text] [Related]
8. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic features of congenital dyserythropoietic anemia (CDA).
Moreno-Carralero MI; Horta-Herrera S; Morado-Arias M; Ricard-Andrés MP; Lemes-Castellano A; Abio-Calvete M; Cedena-Romero MT; González-Fernández FA; Llorente-González L; Periago-Peralta AM; de-la-Iglesia-Íñigo S; Méndez M; Morán-Jiménez MJ
Eur J Haematol; 2018 Sep; 101(3):368-378. PubMed ID: 29901818
[TBL] [Abstract][Full Text] [Related]
10. New Cases and Mutations in
Musri MM; Venturi V; Ferrer-Cortès X; Romero-Cortadellas L; Hernández G; Leoz P; Ricard Andrés MP; Morado M; Fernández Valle MDC; Beneitez Pastor D; Ortuño Cabrero A; Moreno Gamiz M; Senent Peris L; Perez-Valencia AI; Pérez-Montero S; Tornador C; Sánchez M
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373084
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma.
Sun X; Jin Z; Song X; Wang J; Li Y; Qian X; zhang Y; Yin Y
BMC Cancer; 2015 Dec; 15():961. PubMed ID: 26674738
[TBL] [Abstract][Full Text] [Related]
12. Congenital dyserythropoietic anemia, type II with SEC23B exon 12 c.1385 A → G mutation, and pseudo-Gaucher cells in two siblings.
Sharma P; Das R; Bansal D; Trehan A
Hematology; 2015 Mar; 20(2):104-7. PubMed ID: 24801240
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis and copy number alterations of
Vikberg AL; Vooder T; Lokk K; Annilo T; Golovleva I
Onco Targets Ther; 2017; 10():4969-4979. PubMed ID: 29066916
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and genetics of congenital dyserythropoietic anemias (CDA)].
Rössler J; Havers W
Klin Padiatr; 2000; 212(4):153-8. PubMed ID: 10994542
[TBL] [Abstract][Full Text] [Related]
15. KIF23 Promotes Gastric Cancer by Stimulating Cell Proliferation.
Li XL; Ji YM; Song R; Li XN; Guo LS
Dis Markers; 2019; 2019():9751923. PubMed ID: 31007778
[TBL] [Abstract][Full Text] [Related]
16. Kinesin family member 23 (KIF23) contributes to the progression of bladder cancer cells in vitro and in vivo.
Yao DW; Song Q; He XZ
Neoplasma; 2021 Mar; 68(2):298-306. PubMed ID: 33231086
[TBL] [Abstract][Full Text] [Related]
17. KIF23 is an independent prognostic biomarker in glioma, transcriptionally regulated by TCF-4.
Sun L; Zhang C; Yang Z; Wu Y; Wang H; Bao Z; Jiang T
Oncotarget; 2016 Apr; 7(17):24646-55. PubMed ID: 27013586
[TBL] [Abstract][Full Text] [Related]
18. Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25.
Lind L; Sandström H; Wahlin A; Eriksson M; Nilsson-Sojka B; Sikström C; Holmgren G
Hum Mol Genet; 1995 Jan; 4(1):109-12. PubMed ID: 7711721
[TBL] [Abstract][Full Text] [Related]
19. KLF1 mutation E325K induces cell cycle arrest in erythroid cells differentiated from congenital dyserythropoietic anemia patient-specific induced pluripotent stem cells.
Kohara H; Utsugisawa T; Sakamoto C; Hirose L; Ogawa Y; Ogura H; Sugawara A; Liao J; Aoki T; Iwasaki T; Asai T; Doisaki S; Okuno Y; Muramatsu H; Abe T; Kurita R; Miyamoto S; Sakuma T; Shiba M; Yamamoto T; Ohga S; Yoshida K; Ogawa S; Ito E; Kojima S; Kanno H; Tani K
Exp Hematol; 2019 May; 73():25-37.e8. PubMed ID: 30876823
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of KIF23 predicts clinical outcome in primary lung cancer patients.
Kato T; Wada H; Patel P; Hu HP; Lee D; Ujiie H; Hirohashi K; Nakajima T; Sato M; Kaji M; Kaga K; Matsui Y; Tsao MS; Yasufuku K
Lung Cancer; 2016 Feb; 92():53-61. PubMed ID: 26775597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
